SCHEMBL2716504

SCHEMBL2716504

CCOc1nc2cccc(OC(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 2/20 0.64
PPARG P37231 4/20 0.53
ABCB11 O95342 1/20 0.53
EGFR P00533 1/20 0.53
ERBB2 P04626 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CYP2C9 P11712 1/20 0.53
ADRB3 P13945 1/20 0.53
ADRA2B P18089 1/20 0.53
SLC6A2 P23975 1/20 0.53
TBXAS1 P24557 1/20 0.53
HTR2C P28335 1/20 0.53
AGTR1 P30556 1/20 0.53
HTR2B P41595 1/20 0.53
PDE3A Q14432 1/20 0.53
LTB4R2 Q9NPC1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azilsartan SCHEMBL167538 0.88 AGTR2 (0.72) AGTR2PPARGABCB11EGFRERBB2
Azilsartan SCHEMBL29687472 0.88 AGTR2 (0.72) AGTR2PPARGABCB11EGFRERBB2
Azilsartan SCHEMBL15552225 0.88 AGTR2 (0.71) AGTR2PPARGABCB11EGFRERBB2
Azilsartan SCHEMBL969381 0.88 AGTR2 (0.71) AGTR2PPARGABCB11EGFRERBB2
SCHEMBL844779 0.88 AGTR2 (0.53) AGTR2PPARGABCB11EGFRERBB2
SCHEMBL19159651 0.86 AGTR2 (0.67) AGTR2PPARGABCB11EGFRERBB2
SCHEMBL965217 0.85 AGTR2 (0.75) AGTR2PPARGABCB11EGFRERBB2
Azilsartan SCHEMBL3770221 0.85 AGTR2 (0.70) AGTR2PPARGABCB11EGFRERBB2
SCHEMBL7015276 0.85 AGTR2 (0.53) AGTR2PPARGABCB11EGFRERBB2
Azilsartan SCHEMBL969380 0.85 AGTR2 (0.70) AGTR2PPARGABCB11EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1787647-B1 REMEDY FOR GLOMERULAR DISEASES KOWA CO (JP) 2012-06-20 EP claimed
EP-1990052-B1 PHARMACEUTICAL PACKAGE COMPRISING 2-ETHOXY-1-{[2'-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)BIPHENYL-4-YL]METHYL}-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL OR 2-CYCLOPROPYL-1-{[2'-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)BIPHENYL-4-YL]METHYL}-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL AND A DESICCANT. TAKEDA PHARMACEUTICAL (JP) 2012-05-16 EP claimed
EP-2058010-B1 PHARMACEUTICAL COMPOSITION TAKEDA PHARMACEUTICAL (JP) 2012-05-02 EP claimed
EP-1718641-B1 BENZIMIDAZOLE DERIVATIVE AND ITS USE AS A II RECEPTOR ANTAGONIST TAKEDA PHARMACEUTICAL (JP) 2007-08-15 EP claimed
EP-1058541-B1 SUSTAINED-RELEASE PREPARATION FOR AII ANTAGONIST, PRODUCTION AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-01-28 EP claimed
EP-0612523-B1 Vascular hypertrophy suppressor TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-06-12 EP claimed
EP-0622077-B1 Angiotensin II antagonists as a prophylactic or therapeutic drug for renal diseases TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-07-05 EP claimed
EP-0612524-B1 Angiotensin II antagonists for the treatment of viral diseases TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-08-26 EP claimed
CN-104119326-B Method for preparing azilsartan 正大天晴药业集团股份有限公司 2017-04-26 CN disclosed
CN-104119326-A Method for preparing azilsartan CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD 2014-10-29 CN disclosed